Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts Can You Invest in Neuralink? February 4, 2026 Westport Announces $6.5 Million Milestone Payment From Light-Duty Divestiture February 4, 2026 Osisko Metals Closes C$15 Million “Bought-Deal” Flow-Through Share Financing February 4, 2026